A possible explanation is that other Golgi proteins, such as PAQR11 [17] and PI4K2A [12], which are highly expressed in mesenchymal cancer cells, may compensate for the changes in Golgi morphology caused by ACBD3 loss. This evidence concerns the gene PI4K2A and cancer.